Latest Accounting News

Page 19 of 150
Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.
Victor Sage
Victor Sage
6 Nov 2025
Clime Capital reports an unaudited pre-tax NTA of 78.55 cents per share and announces a December quarter dividend guidance of 1.35 cents, maintaining an active share buyback program.
Claire Turing
Claire Turing
6 Nov 2025
Growthpoint Properties Australia kicks off FY26 with robust leasing activity, high occupancy rates, and a strategic $24 million industrial acquisition, maintaining its financial guidance and sustainability credentials.
Eva Park
Eva Park
6 Nov 2025
National Australia Bank reported a 1% increase in underlying profit for FY25 with stable cash earnings and a steady fully franked dividend of 85 cents per share. The bank’s refreshed strategy shows early momentum despite rising credit impairment charges.
Claire Turing
Claire Turing
6 Nov 2025
National Australia Bank reported a 1.2% revenue increase to $20.872 billion in FY25, while net profit dipped 2.9% to $6.759 billion. The bank highlighted progress in customer-centric strategy, technology modernization, and sustainability initiatives.
Claire Turing
Claire Turing
6 Nov 2025
Santana Minerals has been granted a crucial 25-year mining permit for its Bendigo-Ophir Gold Project in New Zealand, paving the way for construction and gold production pending environmental approvals.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Nova Eye Medical reported a 20% year-on-year revenue increase in Q1 FY26, reaffirming its FY26 sales guidance and targeting breakeven EBITDA by June 2026 amid cautious commercial expansion.
Ada Torres
Ada Torres
5 Nov 2025
4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.
Ada Torres
Ada Torres
5 Nov 2025
Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.
Ada Torres
Ada Torres
5 Nov 2025
Austin Engineering has lowered its FY26 revenue and EBIT forecasts due to challenges in key contracts and operational inefficiencies, while outlining strategic measures to restore profitability.
Victor Sage
Victor Sage
5 Nov 2025
Odyssey Gold reports impressive drilling results at its Tuckanarra Project in Western Australia, confirming strong gold mineralisation and advancing resource upgrades. The latest intersections bolster confidence ahead of a new Mineral Resource Estimate and Scoping Study.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Finbar Group Limited reports a surge in 2025 sales and unveils a robust $1.2 billion development pipeline, capitalizing on Western Australia's booming apartment market driven by strong migration and investor demand.
Eva Park
Eva Park
4 Nov 2025